亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Advanced age is not a barrier to creating a functional arteriovenous fistula: a retrospective study

医学 回顾性队列研究 动静脉瘘 瘘管 血液透析 队列 糖尿病 单中心 外科 内科学 内分泌学
作者
Monica Beaulieu,Chance S. Dumaine,Alexandra Romann,Mercedeh Kiaii
出处
期刊:Journal of Vascular Access [SAGE Publishing]
卷期号:18 (4): 307-312 被引量:11
标识
DOI:10.5301/jva.5000710
摘要

Introduction Arteriovenous fistulas (AVFs) are the recommended form of vascular access for hemodialysis. However, controversy exists regarding whether AVFs are suitable for elderly patients. Methods Single-center retrospective review to investigate the impact of age on AVF outcomes. Five hundred and twenty-five patients with AVF creation were stratified based on age <65, 65-75, and >75 years. AVF outcomes including primary failure, AVF patency (primary, secondary, and functional), and AVF complications were studied for 3 years following AVF creation. Results The cohort was 63% male, 44% Caucasian, and 55% had diabetes or cardiovascular disease. 39% were aged <65 years, 33% 65-75 years, and 28% were aged >75 years. No differences in rates of primary failure, loss of primary patency, complications, or need for intervention were observed between age groups. There was a significant association of age with secondary patency and functional patency, with age >75 being an independent risk factor for shortened lifespan of the fistula. For patients aged >75 years, secondary patency at 3 years was 64% compared to 75%-78% for younger patients. Functional patency at 2 years was 69% for those aged >75 years compared to 78%-81% for younger patients. Conclusions We found no difference in AVF maturation, primary patency, complications, or interventions in those over the age of 75 compared to younger counterparts. While secondary and functional patency rates were significantly lower in those aged >75 years, the magnitude of difference is likely not clinically relevant. Therefore, we recommend that advanced age alone should not preclude patients from AVF creation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
阔达棉花糖完成签到 ,获得积分10
刚刚
顺利豆豆完成签到,获得积分10
1秒前
zxcvvbb1001完成签到 ,获得积分10
5秒前
8秒前
1分钟前
1分钟前
喜滋滋发布了新的文献求助10
1分钟前
Elena发布了新的文献求助10
1分钟前
Ocean完成签到,获得积分10
1分钟前
酷波er应助科研通管家采纳,获得10
1分钟前
丘比特应助Elena采纳,获得10
1分钟前
科研通AI2S应助Raye采纳,获得10
1分钟前
李剑鸿发布了新的文献求助200
1分钟前
1分钟前
顺利豆豆发布了新的文献求助10
1分钟前
Raye发布了新的文献求助10
1分钟前
Elena完成签到,获得积分10
1分钟前
2分钟前
黄玉发布了新的文献求助10
2分钟前
Tayzon完成签到 ,获得积分10
2分钟前
个性画笔发布了新的文献求助60
2分钟前
nickel完成签到,获得积分10
2分钟前
Hello应助黄玉采纳,获得10
2分钟前
浮游应助黄玉采纳,获得10
2分钟前
无花果应助黄玉采纳,获得10
2分钟前
浮游应助黄玉采纳,获得10
2分钟前
科研fw完成签到 ,获得积分10
2分钟前
西安浴日光能赵炜完成签到,获得积分10
2分钟前
charih完成签到 ,获得积分10
2分钟前
慕青应助Acuity采纳,获得10
2分钟前
量子星尘发布了新的文献求助10
2分钟前
2分钟前
Acuity发布了新的文献求助10
2分钟前
华仔应助Acuity采纳,获得10
3分钟前
3分钟前
Acuity发布了新的文献求助10
3分钟前
nolan完成签到 ,获得积分10
3分钟前
传奇3应助科研通管家采纳,获得10
3分钟前
Acuity完成签到,获得积分10
3分钟前
黄玉发布了新的文献求助10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
SOFT MATTER SERIES Volume 22 Soft Matter in Foods 1000
Zur lokalen Geoidbestimmung aus terrestrischen Messungen vertikaler Schweregradienten 1000
Circulating tumor DNA from blood and cerebrospinal fluid in DLBCL: simultaneous evaluation of mutations, IG rearrangement, and IG clonality 500
Food Microbiology - An Introduction (5th Edition) 500
A Systemic-Functional Study of Language Choice in Singapore 400
Architectural Corrosion and Critical Infrastructure 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 4869967
求助须知:如何正确求助?哪些是违规求助? 4160714
关于积分的说明 12902073
捐赠科研通 3915754
什么是DOI,文献DOI怎么找? 2150488
邀请新用户注册赠送积分活动 1168870
关于科研通互助平台的介绍 1071956